Strand’s smart mRNA
How Strand is controlling therapeutic mRNA expression with small molecules
Strand Therapeutics Inc. has developed a method to apply pharmacological control to therapeutic mRNA, enabling the company to regulate when, where and how potently mRNA transcripts are expressed using small molecules. Its initial focus is on delivery of therapeutic mRNA to promote immune responses in cancer.
While strategies for controlling gene therapies, cell
